Vanguard Capital Management Discloses New 7.53% Stake in Thermo Fisher Scientific Inc. (TMO)

On April 30, 2026, Vanguard Capital Management LLC filed a Schedule 13G indicating a significant new ownership position in Thermo Fisher Scientific Inc. (TMO). As of the event date of March 31, 2026, Vanguard reported beneficial ownership of 28,008,822 shares of common stock, representing a 7.53% stake in the company. This filing marks an increase from a previously reported 0% position, establishing Vanguard as a major institutional shareholder. The filing specifies that Vanguard holds sole dispositive power over all 28,008,822 shares, while possessing sole voting power over 3,728,006 shares. The securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The reported holdings include shares managed by various Vanguard affiliates, such as Vanguard Asset Management Limited and Vanguard Global Advisers, LLC. This substantial position reflects Vanguard's increased investment focus on the life sciences tools and services leader.